For laboratories and independent researchers, understanding the nuances of the GLP-1 research peptide is essential for maintaining experimental integrity and achieving reproducible data
Participants in clinical trials not only maintained a reduced body weight of approximately 15% but also experienced improved heart health, stabilized blood sugar levels, less joint pain, increased energy, improved sleep, and heightened self-confidence
The decrease in LV mass and pericardiac adipose tissue might be closely associated with the reduction in HF events that were observed in the main SUMMIT trial [70]
But there are downsides to GLP-1s, and the long-term effects of these medications is still being studied, especially as more people use them for extended periods
The safety of DPP-4 inhibitor and SGLT2 inhibitor combination therapies
Zhou D, Chen YW, Zhao ZH, Yang RX, Xin FZ, Liu XL, et al